These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 19927175)

  • 21. Use of cilostazol for secondary stroke prevention: an old dog with new tricks?
    Ansara AJ; Shiltz DL; Slavens JB
    Ann Pharmacother; 2012 Mar; 46(3):394-402. PubMed ID: 22353234
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antiplatelet cilostazol is beneficial in diabetic and/or hypertensive ischemic stroke patients. Subgroup analysis of the cilostazol stroke prevention study.
    Shinohara Y; Gotoh F; Tohgi H; Hirai S; Terashi A; Fukuuchi Y; Otomo E; Itoh E; Matsuda T; Sawada T; Yamaguchi T; Nishimaru K; Ohashi Y
    Cerebrovasc Dis; 2008; 26(1):63-70. PubMed ID: 18511873
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Addition of cilostazol reduces biological aspirin resistance in aspirin users with ischaemic stroke: a double-blind randomized clinical trial.
    Lee JH; Cha JK; Lee SJ; Ha SW; Kwon SU
    Eur J Neurol; 2010 Mar; 17(3):434-42. PubMed ID: 19922458
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antiplatelet Agents for the Secondary Prevention of Ischemic Stroke or Transient Ischemic Attack: A Network Meta-Analysis.
    Wang W; Zhang L; Liu W; Zhu Q; Lan Q; Zhao J
    J Stroke Cerebrovasc Dis; 2016 May; 25(5):1081-1089. PubMed ID: 26856461
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Meta-analysis of cilostazol versus aspirin for the secondary prevention of stroke.
    Dinicolantonio JJ; Lavie CJ; Fares H; Menezes AR; O'Keefe JH; Bangalore S; Messerli FH
    Am J Cardiol; 2013 Oct; 112(8):1230-4. PubMed ID: 23827403
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cilostazol, a phosphodiesterase inhibitor, prevents no-reflow and hemorrhage in mice with focal cerebral ischemia.
    Hase Y; Okamoto Y; Fujita Y; Kitamura A; Nakabayashi H; Ito H; Maki T; Washida K; Takahashi R; Ihara M
    Exp Neurol; 2012 Jan; 233(1):523-33. PubMed ID: 22173318
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cilostazol prevents the progression of the symptomatic intracranial arterial stenosis: the multicenter double-blind placebo-controlled trial of cilostazol in symptomatic intracranial arterial stenosis.
    Kwon SU; Cho YJ; Koo JS; Bae HJ; Lee YS; Hong KS; Lee JH; Kim JS
    Stroke; 2005 Apr; 36(4):782-6. PubMed ID: 15746463
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cilostazol Addition to Aspirin could not Reduce the Neurological Deterioration in TOAST Subtypes: ADS Post-Hoc Analysis.
    Aoki J; Iguchi Y; Urabe T; Yamagami H; Todo K; Fujimoto S; Idomari K; Kaneko N; Iwanaga T; Terasaki T; Tanaka R; Yamamoto N; Tsujino A; Nomura K; Abe K; Uno M; Okada Y; Matsuoka H; Yamagata S; Yamamoto Y; Yonehara T; Inoue T; Yagita Y; Kimura K;
    J Stroke Cerebrovasc Dis; 2021 Feb; 30(2):105494. PubMed ID: 33278804
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antiplatelet Therapy of Cilostazol or Sarpogrelate with Aspirin and Clopidogrel after Percutaneous Coronary Intervention: A Retrospective Cohort Study Using the Korean National Health Insurance Claim Database.
    Noh Y; Lee J; Shin S; Lim HS; Bae SK; Oh E; Kim GJ; Kim JH; Lee S
    PLoS One; 2016; 11(3):e0150475. PubMed ID: 26939062
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Triflusal and aspirin in the secondary prevention of atherothrombotic ischemic stroke: a very long-term follow-up.
    Alvarez-Sabín J; Quintana M; Santamarina E; Maisterra O
    Cerebrovasc Dis; 2014; 37(3):181-7. PubMed ID: 24503927
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Protective effects of cilostazol against transient focal cerebral ischemia and hemorrhagic transformation].
    Ishiguro M; Hara H
    Yakugaku Zasshi; 2011 Apr; 131(4):513-21. PubMed ID: 21467790
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Platelet inhibition by adjunctive cilostazol suppresses the frequency of cerebral ischemic lesions after carotid artery stenting in patients with carotid artery stenosis.
    Nakagawa I; Wada T; Park HS; Nishimura F; Yamada S; Nakagawa H; Kichikawa K; Nakase H
    J Vasc Surg; 2014 Mar; 59(3):761-7. PubMed ID: 24239116
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The efficacy and safety of cilostazol in ischemic stroke patients with peripheral arterial disease (SPAD): protocol of a randomized, double-blind, placebo-controlled multicenter trial.
    Jeng JS; Sun Y; Lee JT; Lin RT; Chen CH; Po HL; Lin HJ; Liu CH; Sun MH; Sun MC; Chern CM; Lien LM; Chiu HC; Hu HH; Chiou HY; Chen ST; Ma H; Hsu CY;
    Int J Stroke; 2015 Jan; 10(1):123-7. PubMed ID: 25394855
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Results of the Cilostazol Stroke Prevention Study II (CSPS II): a randomized controlled trial for the comparison of cilostazol and aspirin in stroke patients].
    Uchiyama S
    Rinsho Shinkeigaku; 2010 Nov; 50(11):832-4. PubMed ID: 21921460
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Addition of cilostazol to aspirin therapy for secondary prevention of cardiovascular and cerebrovascular disease in patients undergoing percutaneous coronary intervention: A randomized, open-label trial.
    Ueda H; Kido A; Matsuhisa S; Asawa K; Yoshida N; Tsujimoto M; Sasaki Y; Kuga Y; Yamasaki M; Ueda K; Shinohara S; Nishida Y
    Am Heart J; 2016 Mar; 173():134-42. PubMed ID: 26920606
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cilostazol may prevent cerebral vasospasm following subarachnoid hemorrhage.
    Yoshimoto T; Shirasaka T; Fujimoto S; Yoshidumi T; Yamauchi T; Tokuda K; Kaneko S; Kashiwaba T
    Neurol Med Chir (Tokyo); 2009 Jun; 49(6):235-40; discussion 240-1. PubMed ID: 19556731
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aspirin plus clopidogrel
    Ye MB; Chen YL; Wang Q; An J; Ye F; Jing P
    Scand Cardiovasc J; 2019 Aug; 53(4):169-175. PubMed ID: 31112048
    [No Abstract]   [Full Text] [Related]  

  • 38. Antiplatelet cilostazol is effective in the prevention of pneumonia in ischemic stroke patients in the chronic stage.
    Shinohara Y
    Cerebrovasc Dis; 2006; 22(1):57-60. PubMed ID: 16645267
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cilostazol Versus Aspirin in Ischemic Stroke Patients With High-Risk Cerebral Hemorrhage: Subgroup Analysis of the PICASSO Trial.
    Kim BJ; Kwon SU; Park JH; Kim YJ; Hong KS; Wong LKS; Yu S; Hwang YH; Lee JS; Lee J; Rha JH; Heo SH; Ahn SH; Seo WK; Park JM; Lee JH; Kwon JH; Sohn SI; Jung JM; Navarro JC; Kim HY; Kim EG; Kim S; Cha JK; Park MS; Nam HS; Kang DW;
    Stroke; 2020 Mar; 51(3):931-937. PubMed ID: 31856691
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cilostazol shows promise as an alternative to aspirin for patients with ischaemic stroke.
    Hankey GJ
    Lancet Neurol; 2008 Jun; 7(6):469-70. PubMed ID: 18456559
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.